Liver Cancer News

Blue Faery: The Adrienne Wilson Liver Cancer Association

AA

A A

Liver Cancer News

Print Friendly, PDF & Email

Click on the title to read the rest of the Liver Cancer News story.

February 2022

Study Of Cemiplimab Use In Hepatocellular Carcinoma Meets Primary End Points

New Guidelines Clarify Use Of Systemic Therapy In Advanced HCC

New Clinical Trial Of A Non-Invasive Liver Cancer Treatment Set To Commence

Lenvatinib Shows Noninferior Survival Outcomes And Improved PFS In HCC

Expert: Patients With Cirrhosis Have A ‘Sufficiently High Risk’ For Liver Cancer

AGA Recommends Shared Decision-Making Approach For Treatment Of Hepatocellular Carcinoma (HCC)

Targeting Cancer: Patient Thriving Two Years After Terminal Liver Cancer Diagnosis

Award-Winning Singer And Songwriter Maranda Curtis Joins Forces With Blue Faery To Fight Liver Cancer

Doctoral Student Studying Liver Cancer Earns Prestigious Fellowship

FDA Grants Orphan Drug Designation To T-Cell Therapies For Advanced Liver Cancer

Ghassan K. Abou-Alfa, MD, Discusses Patient Population And Dosing For HCC In HIMALAYA Trial

ASTRO Offers Guidance On EBRT For Primary Liver Cancers

The Blue Faery “Love Your Liver” Public Awareness Campaign

Liver Cirrhosis Has Higher Hospitalization And In-Hospital Mortality Rates In Germany

Vaccines For Cancer Are Already Here – And You Can Get Them

Prevention Of Liver Cancer

FOHAIC-1 Study Shows Positive Results In Hepatocellular Carcinoma

Tremelimumab/Durvalumab Combo Promising For Unresectable HCC

Liver Cancer In Hispanic And Latino Communities: What You Need To Know

Biomarkers In Saliva May Detect Hepatocellular Carcinoma

Researchers Restore Function In A Gene That Can Suppress Liver Cancer And Enhance Immunotherapy

Ghassan K. Abou-Alfa, MD, On Integral Developments Leading To Phase 3 HIMALAYA Trial In Hepatocellular Carcinoma

Liver Cancer Symptoms: What To Spot In Your Poo – ‘Make An Appointment With Your Doctor’

Antihistamines May Reduce Risk Of Hepatocellular Carcinoma In Patients With Viral Hepatitis

Cutting Off Liver Cancer’s Nutrient Supply Chain

Hepatocellular Carcinoma Over the Past Decade

Study Assesses Real-World Outcomes Of Immunotherapy In Patients With HCC, Comorbidities

Study Of A Tremelimumab-Imfinzi Combination May Lead To New Liver Cancer Treatment Strategy

VIDEO: Use Of Radiation Therapy As A Bridge-To-Transplant In Liver Cancer

January 2022

Cemiplimab Promises To Be Effective Against Resectable Liver Cancer

Researchers Develop New Tool To Determine Patients’ Liver Cancer Risk After Hepatitis C

Pre-Op Treatment May Be Advance Against Deadly Liver Cancers

Georgia Cancer Center Researcher Works To Develop New Treatment Options For Liver Cancer

Guerbet Highlights Use Of Lipiodol For Liver Cancer Treatment In India

Innovent, Lilly Report Phase Ib Sintilimab Data In Hepatocellular Carcinoma

First Patient Dosed In Randomised Phase 2 Clinical Trial Of Mtl-Cebpa In Patients With Advanced Liver Cancer

90K People Receive Medical Services Within Early Detection Of Liver Cancer Programme

Microwave Ablation Treatment Effective In Treating Liver Cancer

Combo Immunotherapy Ups Survival In Advanced Liver Cancer

Stride Regimen Extends Survival In Unresectable Hepatocellular Carcinoma

Innovent And Eli Lilly And Company Announced Final Clinical Results And Biomarker Analysis Of Phase Ib Study Of Tyvyt® (Sintilimab Injection) Plus Bevacizumab Biosimilar Injection For Advanced Hepatocellular Carcinoma

Minimally Invasive Procedure Combined With Lenvima And Checkpoint Blockade Shows Promise In Unresectable Liver Cancer

Pembrolizumab Plus Bsc Shows Significant Survival Benefit In Advanced HCC

Tica Leads Research In The United States For The Treatment Of Advanced Liver Cancer

Abivax Abx196 Shows Benefit In Liver Cancer Patients In Phase 1/2 Trial

Libtayo Effective In Killing HCC Tumors Prior To Resection

Merck’s Keytruda Narrowly Passes Liver Cancer Confirmatory Trial, But Murky Fda Fate Lies Ahead

Optical Biopsy System Cuts Potential For Misdiagnoses Of Liver Cancer

Guideline Issued For External Beam Rt In Primary Liver Cancers

Researchers Identify Novel Pathways Responsible For Liver Cancer

Durvalumab Plus Tremelimumab Improves Os In Unresectable HCC

Phase 3 Data For Pembrolizumab In Hepatocellular Carcinoma Show Significant Improvements

The Promise Of Tislelizumab In Unresectable HCC

Nanoparticles With A Mega Impact: How Injectable Mrna Fights Cancer

Surefire Ways To Protect Your Liver

Supplements Warning: Two ‘Natural’ Supplements Causing Deadly ‘Toxic Liver Disease’

Research In Oklahoma City Could Be A Game-Changer For Thousands On Liver Transplant List

Scientists Discover Cytochrome P450 Family Member Cyp39a1 Can Block Hepatocarcinogenesis

UT Southwestern Develops Nanotherapeutic To Ward Off Liver Cancer

Nivolumab Achieves Durable Responses And Extends Os Versus Sorafenib In HCC

Captor Therapeutics Presents Compelling In Vivo Proof-Of-Concept Data From Ct-01 Program In Hepatocellular Carcinoma

RNA Discovery May Lead To Better Diagnosis And Treatment Of Liver Cancer

New Drug Combo Identified For Liver Cancer Via Crispr-Cas9 Screen

Liver Cancer: The Warning Sign Under Your Ribs And 16 Other Symptoms Of The Disease

Can Non-Invasive Medical Devices Help Halt Liver Disease?

Cancer: The Popular Hot Drink Shown To Slash The Risk Of Liver Cancer By 40%

New Guidance In Place To Lower Incidence Of Liver Cancer

Dr. Khushman On Best Practices In The Management Of GI Cancers

Clinical Trial Underway In Miami-Dade For Treatment Of Liver Tumors

Researchers Develop Optical Biopsy System That Detects Liver Cancer

Promising Phase II Results For Hard-To-Treat Liver Disease

Knight Therapeutics Inc. Announces Approval Of Lenvima® In Colombia

Korean Firm Gc Cell To Expand Availability Of Immuncell-Lc For Liver Cancer

Microwave Ablation Performed To Treat Liver Cancer

Harbour Biomed Announces Dosing Of First Patient Of Two Phase I Trials For Next-Generation Anti-Ctla-4 Antibody Hbm4003

First-Line Nivolumab Does Not Improve Survival In Advanced Hepatocellular Carcinoma

FDA Grants Fast Track Designation To Tcr T-Cell Therapy For Hepatocellular Carcinoma

Dr. Manne On The Need For Novel Therapies In HCC Without Preserved Liver Function

Unresectable HCC: Interpreting Data From The Imbrave150 Trial

Defining The Role Of Adjuvant Therapy For HCC

Case 3: A Patient With Metastatic HCC

Fatty Liver Disease Symptoms: Encephalopathy Can Be A Sign – What Is It?

Puerto Ricans Continue To Be At Higher Risk Of Developing Hepatocellular Cancer

 

For past liver cancer news, please visit our Liver Cancer News Archives.